Menopause Hormone Therapy (HRT) in Richmond, KY

Bioidentical hormones in Richmond: what it means

If you are one of the 2,913 women aged 45 to 64 in Richmond and have searched for "bioidentical" hormones: the word means a hormone whose structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

9 OB-GYNs in the federal NPI registry give a primary practice address in Richmond: 25.4 per 100,000 residents, above the US rate of 17.8 and above Kentucky's 15.6, and more per resident than 62% of the 924 cities VevaMD covers. That is about 320 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Within 25 miles of Richmond there are 119 OB-GYNs for 458,291 residents (26.0 per 100,000), well above the national rate; 9 are in the city or within 10 miles. None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in Kentucky reviewing your answers from home in Richmond.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Kentucky decides what, if anything, fits, and the form. Pellets are not part of it. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11